Literature DB >> 2664512

Bone marrow transplantation after the Chernobyl nuclear accident.

A Baranov1, R P Gale, A Guskova, E Piatkin, G Selidovkin, L Muravyova, R E Champlin, N Danilova, L Yevseeva, L Petrosyan.   

Abstract

On April 26, 1986, an accident at the Chernobyl nuclear power station in the Soviet Union exposed about 200 people to large doses of total-body radiation. Thirteen persons exposed to estimated total-body doses of 5.6 to 13.4 Gy received bone marrow transplants. Two transplant recipients, who received estimated doses of radiation of 5.6 and 8.7 Gy, are alive more than three years after the accident. The others died of various causes, including burns (the cause of death in five), interstitial pneumonitis (three), graft-versus-host disease (two), and acute renal failure and adult respiratory distress syndrome (one). There was hematopoietic (granulocytic) recovery in nine transplant recipients who could be evaluated, six of whom had transient partial engraftment before the recovery of their own marrow. Graft-versus-host disease was diagnosed clinically in four persons and suspected in two others. Although the recovery of endogenous hematopoiesis may occur after exposure to radiation doses of 5.6 to 13.4 Gy, we do not know whether it is more likely after the transient engraftment of transplanted stem cells. Because large doses of radiation affect multiple systems, bone marrow recovery does not necessarily ensure survival. Furthermore, the risk of graft-versus-host disease must be considered when the benefits of this treatment are being weighed.

Entities:  

Mesh:

Year:  1989        PMID: 2664512     DOI: 10.1056/NEJM198907273210401

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

1.  Overview: effects of radiation on the human body: acute and chronic sequelae in hematopoietic organs.

Authors:  Masao Tomonaga
Journal:  Int J Hematol       Date:  2012-02-29       Impact factor: 2.490

2.  To survive radiation injury, remember your aPCs.

Authors:  John P Chute
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 3.  Current status of hematopoietic stem cell transplantation for acute radiation syndromes.

Authors:  Shigetaka Asano
Journal:  Int J Hematol       Date:  2012-03-03       Impact factor: 2.490

Review 4.  First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation.

Authors:  Nicholas Dainiak; Robert Nicolas Gent; Zhanat Carr; Rita Schneider; Judith Bader; Elena Buglova; Nelson Chao; C Norman Coleman; Arnold Ganser; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Viktor Meineke
Journal:  Disaster Med Public Health Prep       Date:  2011-10-10       Impact factor: 1.385

5.  Fast image analysis for the micronucleus assay in a fully automated high-throughput biodosimetry system.

Authors:  Oleksandra V Lyulko; Guy Garty; Gerhard Randers-Pehrson; Helen C Turner; Barbara Szolc; David J Brenner
Journal:  Radiat Res       Date:  2014-02-06       Impact factor: 2.841

6.  Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death.

Authors:  Eva C Guinan; Christine M Barbon; Leslie A Kalish; Kalindi Parmar; Jeff Kutok; Christy J Mancuso; Liat Stoler-Barak; Eugénie E Suter; Janice D Russell; Christine D Palmer; Leighanne C Gallington; Annie Voskertchian; Jo-Anne Vergilio; Geoffrey Cole; Kaya Zhu; Alan D'Andrea; Robert Soiffer; Jerrold P Weiss; Ofer Levy
Journal:  Sci Transl Med       Date:  2011-11-23       Impact factor: 17.956

7.  Interleukin-3 in combination with granulocyte-macrophage-colony-stimulating factor following bone marrow transplantation in a radiation accident victim.

Authors:  A Nagler; E Naparstek; P Drakos; C Brautbar; M Goldman; O Kaplan; A Fridmann; S Slavin
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

8.  rBPI21 (Opebacan) Promotes Rapid Trilineage Hematopoietic Recovery in a Murine Model of High-Dose Total Body Irradiation.

Authors:  Kenneth J Janec; Huaiping Yuan; James E Norton; Rowan H Kelner; Christian K Hirt; Rebecca A Betensky; Eva C Guinan
Journal:  Am J Hematol       Date:  2018-05-11       Impact factor: 10.047

9.  Potential for a pluripotent adult stem cell treatment for acute radiation sickness.

Authors:  Denis O Rodgerson; Bruce E Reidenberg; Alan G Harris; Andrew L Pecora
Journal:  World J Exp Med       Date:  2012-06-20

Review 10.  Principles and overview of allogeneic hematopoietic stem cell transplantation.

Authors:  Sergio Giralt; Michael R Bishop
Journal:  Cancer Treat Res       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.